PRESS RELEASE published on 03/04/2026 at 07:03, 1 month 15 days ago EQS-Adhoc: adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board. Key personnel decisions announced Supervisory Board Chief Executive Officer Personnel Decisions Adidas AG Bjørn Gulden
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 1 month 15 days ago TERACT - Availibility of the Half-year Financial Report As of 31 December 2025 TERACT announces availability of its half-year financial report as of 31 December 2025, compliant with regulations, filed with AMF and accessible on company and AMF websites Financial Statements TERACT AMF Regulations Half-year Financial Report
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 1 month 15 days ago TERACT - Mise à disposition du Rapport Financier Semestriel au 31 décembre 2025 TERACT annonce la mise à disposition de son Rapport Financier Semestriel au 31 décembre 2025 conforme à la réglementation en vigueur. Consultation possible sur www.teract.com ou le site de l'AMF TERACT AMF Investisseurs Publication Rapport Financier Semestriel
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 1 month 15 days ago TERACT - H1 2025-2026 results TERACT's H1 2025-2026 results impacted by store disposals amid sluggish market conditions. InVivo Group proposes public buy-out and squeeze-out of TERACT shares to support new roadmap TERACT Results Store Disposals InVivo Group H1 2025-2026
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 1 month 15 days ago TERACT - Résultats du 1er semestre 2025-2026
PRESS RELEASE published on 03/04/2026 at 07:00, 1 month 15 days ago Fourth quarter 2025 Results - EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million - Proposed regular dividend of EUR 1.9 per share SCOR SE reports EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million. Proposed regular dividend of EUR 1.9 per share approved by the Board Financial Results Net Income Dividend Scor SE Q4 2025
PRESS RELEASE published on 03/04/2026 at 07:00, 1 month 15 days ago BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy BioVersys announces publication of BV100 Phase 1 clinical data in Journal of Antimicrobial Agents and Chemotherapy Clinical Data Phase 1 BV100 BioVersys Antibacterial
PRESS RELEASE published on 03/04/2026 at 06:45, 1 month 15 days ago Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy. Anja Hendel, Max Müller and Peter Schmid von Linstow nominated to Redcare Pharmacy's Supervisory Board, enhancing expertise & strategic oversight. Björn Söder, Jérôme Cochet, Jaska de Bakker to step down Governance Supervisory Board Expertise Redcare Pharmacy Nominees
PRESS RELEASE published on 03/04/2026 at 06:44, 1 month 15 days ago PALFINGER AG – THIRD-BEST FISCAL YEAR IN THE COMPANY'S HISTORY AND FOCUS ON PROFITABLE GROWTH PALFINGER AG reports third-best fiscal year, with EUR 2.34 billion revenue, EUR 174.3 million EBIT, and focus on profitable growth. Strong balance sheet and global expansion strategies Global Expansion Financial Performance Profitable Growth Fiscal Year PALFINGER AG
PRESS RELEASE published on 03/04/2026 at 06:30, 1 month 15 days ago Redcare Pharmacy: Strong growth in 2025 surpassing EUR 1bn in Rx revenue; adj. EBITDA up 72% yoy. Redcare Pharmacy reports strong growth in 2025, surpassing EUR 1bn in Rx revenue with adj. EBITDA up 72% yoy. Active customers grow to 13.9M. Guidance for 2026: 13%-15% revenue growth, adj. EBITDA margin 2.5% Adjusted EBITDA Redcare Pharmacy 2025 Growth Rx Revenue 2026 Guidance
Published on 04/18/2026 at 04:00, 1 day 6 hours ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 1 day 8 hours ago AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 1 day 9 hours ago Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 1 day 9 hours ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 1 day 10 hours ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Published on 04/18/2026 at 00:05, 1 day 10 hours ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 21:39, 1 day 13 hours ago Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Published on 04/17/2026 at 20:33, 1 day 14 hours ago LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:30, 1 day 15 hours ago KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 20:30, 1 day 14 hours ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/17/2026 at 19:00, 1 day 15 hours ago Cegedim : Publication du Document d’Enregistrement Universel 2025
Published on 04/17/2026 at 19:00, 1 day 15 hours ago Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 1 day 17 hours ago Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 17:45, 1 day 17 hours ago Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın